| Title |
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
|
|---|---|
| Published in |
JACC, June 2019
|
| DOI | 10.1016/j.jacc.2019.03.513 |
| Pubmed ID | |
| Authors |
David M. Charytan, Marc S. Sabatine, Terje R. Pedersen, KyungAh Im, Jeong-Gun Park, Armando Lira Pineda, Scott M. Wasserman, Prakash Deedwania, Anders G. Olsson, Peter S. Sever, Anthony C. Keech, Robert P. Giugliano, FOURIER Steering Committee and Investigators |
X Demographics
The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 17% |
| Spain | 4 | 11% |
| Romania | 2 | 6% |
| Italy | 1 | 3% |
| United Kingdom | 1 | 3% |
| Malaysia | 1 | 3% |
| Argentina | 1 | 3% |
| Philippines | 1 | 3% |
| Turkey | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 18 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 75% |
| Practitioners (doctors, other healthcare professionals) | 4 | 11% |
| Scientists | 3 | 8% |
| Science communicators (journalists, bloggers, editors) | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 127 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 15 | 12% |
| Other | 12 | 9% |
| Researcher | 12 | 9% |
| Student > Ph. D. Student | 10 | 8% |
| Student > Postgraduate | 7 | 6% |
| Other | 25 | 20% |
| Unknown | 46 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 40% |
| Nursing and Health Professions | 8 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Sports and Recreations | 2 | 2% |
| Other | 10 | 8% |
| Unknown | 50 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 October 2022.
All research outputs
#858,675
of 25,385,509 outputs
Outputs from JACC
#2,159
of 16,743 outputs
Outputs of similar age
#18,832
of 363,722 outputs
Outputs of similar age from JACC
#75
of 216 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,743 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.0. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,722 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.